Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and the National Lung Cancer Partnership
Michele Cote, PhD
Wayne State University, Karmanos Cancer Institute
Detroit
MI
Dr. Cote is examining the role of estrogen-related tumor characteristics in predicting differences in survival between men and women after a lung cancer diagnosis. The identification of molecular and genetic profiles associated with survival will help target treatment advances and customize treatment for male and female lung cancer patients.